
Sign up to save your podcasts
Or
Washington correspondent John Wilkerson joins to discuss why drugmakers have not lobbied against Robert F. Kennedy Jr.'s nomination to lead the Department of Health and Human Services, despite his repeated criticisms of the pharmaceutical industry. We also bring on our colleague Jason Mast to talk about the major hurdles in the field of gene therapy and how one father is trying to overcome them.
4.6
300300 ratings
Washington correspondent John Wilkerson joins to discuss why drugmakers have not lobbied against Robert F. Kennedy Jr.'s nomination to lead the Department of Health and Human Services, despite his repeated criticisms of the pharmaceutical industry. We also bring on our colleague Jason Mast to talk about the major hurdles in the field of gene therapy and how one father is trying to overcome them.
1,641 Listeners
4,310 Listeners
111,673 Listeners
469 Listeners
117 Listeners
5,905 Listeners
2,929 Listeners
384 Listeners
60 Listeners
84 Listeners
31 Listeners
141 Listeners
9 Listeners
193 Listeners
43 Listeners